Open AccessMiller Fisher Syndrome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic Review
Author(s) -
Paulo Ricardo MartinsFilho,
Ana Luiza Pereira de Andrade,
Maria Daniella Moura da Silva,
Adriano Antunes de Souza Araújo,
Paula Santos Nunes,
Victor Santana Santos,
Lis Campos Ferreira,
Eduardo Almeida Neves,
Lucindo José QuintansJúnior
Publication year - 2021
Publication title -
journal of clinical neurology/the journal of clinical neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.208
H-Index - 45
eISSN - 2005-5013
pISSN - 1738-6586
DOI - 10.3988/jcn.2021.17.4.541
Subject(s) - medicine , ataxia , ophthalmoparesis , guillain barre syndrome , immunology , polyneuropathy , pneumonia , antibody , viral encephalitis , encephalitis , virus , psychiatry
Miller Fisher syndrome (MFS) is a subtype of Guillain-Barré syndrome characterized by the triad of ophthalmoparesis, areflexia, and ataxia. Although cases of MFS have been associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, no studies have synthesized the clinical characteristics of patients with this condition.